Home/Filings/4/0000950170-24-014898
4//SEC Filing

PERRY DAVID P 4

Accession 0000950170-24-014898

CIK 0001832415other

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 9:50 PM ET

Size

11.0 KB

Accession

0000950170-24-014898

Insider Transaction Report

Form 4
Period: 2024-02-09
PERRY DAVID P
DirectorSee Remarks10% Owner
Transactions
  • Award

    Common Stock

    2024-02-09$0.19/sh+839,895$160,0002,416,634 total
Holdings
  • Common Stock

    (indirect: By Trust)
    13,030,393
  • Common Stock

    (indirect: By Trust)
    3,636,364
  • Common Stock

    (indirect: By Spouse)
    293,150
  • Common Stock

    (indirect: By Trust)
    21,336
Transactions
  • Award

    Common Stock

    2024-02-09$0.19/sh+839,895$160,0002,416,634 total
Holdings
  • Common Stock

    (indirect: By Trust)
    21,336
  • Common Stock

    (indirect: By Trust)
    13,030,393
  • Common Stock

    (indirect: By Trust)
    3,636,364
  • Common Stock

    (indirect: By Spouse)
    293,150
Footnotes (5)
  • [F1]On February 9, 2024, the Issuer entered into a Securities Purchase Agreement with David P. Perry ("Perry") in a private placement offering, pursuant to which Perry agreed to purchase shares of Issuer common stock for $0.1905 per share.
  • [F2]These shares are owned directly by the David P. Perry 2015 Trust (the "Perry Trust"), a ten percent owner of the Issuer and of which Perry is trustee. Perry disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that Perry is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F3]These shares are owned directly by the Georgianna Maule-Ffinch 2015 Trust (the "Maule-Ffinch Trust") of which Perry's spouse, Georgianna Maule-Ffinch ("Maule-Ffinch"), is sole trustee, for the benefit of Maule-Ffinch and her children. Perry disclaims beneficial ownership of these securities, and the filing of this Form 4 is not an admission that Perry is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F4]These shares are owned directly by Maule-Ffinch.
  • [F5]These shares are owned directly by Doland R. Leo, Trustee of Pensus Limited Trust dated 06/12/2010 FBO Georgianna Maule-Ffinch (the "Pensus Limited Trust") for the benefit of Maule-Ffinch. Perry disclaims beneficial ownership of these securities, and the filing of this Form 4 is not an admission that Perry is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Documents

1 file

Issuer

Better Therapeutics, Inc.

CIK 0001832415

Entity typeother

Related Parties

1
  • filerCIK 0001105941

Filing Metadata

Form type
4
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 9:50 PM ET
Size
11.0 KB